These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24089567)

  • 41. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.
    Djaoud Z; Guethlein LA; Horowitz A; Azzi T; Nemat-Gorgani N; Olive D; Nadal D; Norman PJ; Münz C; Parham P
    J Exp Med; 2017 Jun; 214(6):1827-1841. PubMed ID: 28468758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NK-cells have an impaired response to acute exercise and a lower expression of the inhibitory receptors KLRG1 and CD158a in humans with latent cytomegalovirus infection.
    Bigley AB; Lowder TW; Spielmann G; Rector JL; Pircher H; Woods JA; Simpson RJ
    Brain Behav Immun; 2012 Jan; 26(1):177-86. PubMed ID: 21933704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
    Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
    Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamic Changes in Natural Killer Cell Subset Frequencies in the Absence of Cytomegalovirus Infection.
    Gyurova IE; Schlums H; Sucharew H; Ambroggio L; Ochayon DE; Win HT; Bryceson YT; Bernstein DI; Waggoner SN
    Front Immunol; 2019; 10():2728. PubMed ID: 31824507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections.
    Lee S; Doualeh M; Affandi JS; Makwana N; Irish A; Price P
    J Med Virol; 2019 Jun; 91(6):1120-1127. PubMed ID: 30636352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
    Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
    Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C
    Nerreter T; Zeiß S; Herrmann T; Einsele H; Seggewiss-Bernhardt R
    Immunobiology; 2017 May; 222(5):719-725. PubMed ID: 28139257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
    Boutboul F; Puthier D; Appay V; Pellé O; Ait-Mohand H; Combadière B; Carcelain G; Katlama C; Rowland-Jones SL; Debré P; Nguyen C; Autran B
    AIDS; 2005 Nov; 19(17):1981-6. PubMed ID: 16260904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical features of mononucleosis because of Epstein-Barr virus and cytomegalovirus co-infection in adult patients].
    Li L; Lin F; Jia Y; Liang JJ; Xu J
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3068-3071. PubMed ID: 29081150
    [No Abstract]   [Full Text] [Related]  

  • 54. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytomegalovirus and Epstein-Barr virus coinfection in three toddlers with prolonged illnesses.
    Ito Y; Shibata-Watanabe Y; Kawada J; Maruyama K; Yagasaki H; Kojima S; Kimura H
    J Med Virol; 2009 Aug; 81(8):1399-402. PubMed ID: 19551835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.
    Park SS; Cho SY; Han E; Min GJ; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Cho SG; Lee JW
    Eur J Haematol; 2019 Oct; 103(4):433-441. PubMed ID: 31381187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients.
    Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Heredia G; Pérez-Sáez MJ; Vila J; Costa-García M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
    Am J Transplant; 2020 Mar; 20(3):663-676. PubMed ID: 31612635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analytical and Clinical Performance of the NeuMoDx™ Platform for Cytomegalovirus and Epstein-Barr Virus Viral Load Testing.
    Coupland L; Woodward K; Dervisevic S; Hale R; Brolly S
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
    Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
    PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.